Invention Grant
- Patent Title: Antiglucocorticoid therapy for the prevention of neurological damage in premature infants
- Patent Title (中): 用于预防早产儿神经损伤的抗糖皮质激素治疗
-
Application No.: US13034478Application Date: 2011-02-24
-
Publication No.: US08741880B2Publication Date: 2014-06-03
- Inventor: Joseph K. Belanoff
- Applicant: Joseph K. Belanoff
- Applicant Address: US CA Menlo Park
- Assignee: Corcept Therapeutics, Inc.
- Current Assignee: Corcept Therapeutics, Inc.
- Current Assignee Address: US CA Menlo Park
- Agency: Kilpatrick Townsend & Stockton LLP
- Main IPC: A61K31/56
- IPC: A61K31/56
Abstract:
This invention pertains to the discovery that agents which inhibit the binding of cortisol to its receptors can be used in methods for preventing neurological damage associated with glucocorticoid therapy in ventilator-dependent low birth weight preterm infants. Mifepristone, a potent glucocorticoid receptor antagonist, can be used in these methods.
Public/Granted literature
- US20110144072A1 Antiglucocorticoid Therapy for the Prevention of Neurological Damage in Premature Infants Public/Granted day:2011-06-16
Information query
